Substituted phthalazines for inducing insulin secretion and protecting beta-cells
    2.
    发明授权
    Substituted phthalazines for inducing insulin secretion and protecting beta-cells 有权
    用于诱导胰岛素分泌和保护β-细胞的取代的酞嗪

    公开(公告)号:US09278098B2

    公开(公告)日:2016-03-08

    申请号:US14524724

    申请日:2014-10-27

    IPC分类号: C07D237/32 A61K31/502

    CPC分类号: A61K31/502 C07D237/32

    摘要: Phthalazine analogs of a Lisofylline (LSF) and synthetic methods for preparation of such analogs are provided. Compounds of the invention have structural formula III: wherein 1) R3a is hydrogen and R3b is selected from C5-22alkyl, C2-22alkenyl, or C2-22alkynyl; or a pharmaceutically acceptable salt thereof; or 2) R3b is hydrogen and R3a is selected from C9alkyl, C15-22alkyl, C9-22alkenyl, or C2-22alkynyl; or a pharmaceutically acceptable salt thereof; or 3) R3a and R3b are the same or different and are selected from C9alkyl, C15-22alkyl, C4-22alkenyl, or C2-22alkynyl; or a pharmaceutically acceptable salt thereof. The analogs of LSF provided have the ability to protect cell viability, particularly the ability to protect pancreatic β-cells, to induce insulin secretion.

    摘要翻译: 提供莱索菲线(LSF)的酞嗪类似物和制备此类类似物的合成方法。 本发明化合物具有结构式III:其中1)R3a是氢,R3b选自C5-22烷基,C2-22烯基或C2-22炔基; 或其药学上可接受的盐; 或2)R3b是氢,R3a选自C9烷基,C15-22烷基,C9-22烯基或C2-22炔基; 或其药学上可接受的盐; 或3)R 3a和R 3b相同或不同,并且选自C 9烷基,C 15-22烷基,C 4-22烯基或C 2-22炔基; 或其药学上可接受的盐。 提供的LSF的类似物具有保护细胞活力的能力,特别是保护胰腺和细胞的能力以诱导胰岛素分泌。